J&J unit begins clinical trial of Incraft stent

04/13/2010 | Clinica (subscription required)

Johnson & Johnson's Cordis unit has begun a nonrandomized trial designed to test the ability of its Incraft stent in treating patients with abdominal aortic aneurysm. The device features an ultra-low-profile delivery system and can be tailored to an individual patient during implantation.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Compliance Analyst
ACell, Inc.
Columbia, MD
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR